Background: Zanthoxylum zanthoxyloides and Z. leprieurii fruits are commonly used in traditional system of medicine for diarrhea, pain, wound healing, etc. in Cameroon, Africa. Z. leprieurii fruits have been chemically studied for its bioactive compounds whereas the investigation on Z. zanthoxyloides fruits is lacking. Results: After a detailed chemical analysis of the fruits of Z. leprieurii and Z. zanthoxyloides, a series of new acridone alkaloids, namely, 3-hydroxy-1,5,6-trimethoxy-9-acridone (1), 1,6-dihydroxy-3-methoxy-9-acridone (2), 3,4,5,7-tetrahydroxy-1-methoxy-10-methyl-9-acridone (3), 4-methoxyzanthacridone (8), 4-hydroxyzanthacridone (9), 4-hydroxyzanthacridone oxide (2,4') (10) have been isolated. The known acridones which have been characterized are, helebelicine A (4), 1-hydroxy-3-methoxy-10-methyl-9-acridone (5), 1,3-dihydroxy-4-methoxy-10-methyl-9-acridone (6) and tegerrardin A (7). The in vitro antibacterial and cytotoxic screening of these acridones reveal that compound 3 has a moderate antibacterial activity (MIC 125 μg/mL) against Micrococcus luteus and Pseudomonas aeruginosa while compound 1 shows a moderate cytotoxic effect (IC 50 of 86 μM) against WRL-68 (liver cancer cell line). Furthermore, the molecular modeling of these acridones predicted the structural basis for their mode of action and binding affinity for aromatase, quinone reductase and WAAG, a glycosyltransferase involved in bacterial lipopolysaccharide synthesis. Computational approaches, quantitative SAR and modeling studies predicted that acridones 1, 2, 3, 4, 9 and 10 were the inhibitors of glycosyltransferase while 1, 8, 9 and 10, the inhibitors of aromatase.
Background
The pantropical genus Zanthoxylum (Rutaceae) is represented by 35 species in Africa [1] . Among them, Zanthoxylum zanthoxyloides (Lam.) Zepern. & Timler and Zanthoxylum leprieurii Guill. et Perr are found in Cameroon and are well reputed for their ethnomedicinal properties. Z. zanthoxyloides, formerly known as Fagara zanthoxyloides, a popular African medicinal plant, occurs abundantly in savanna and dry forest vegetations whereas Z. leprieurii, is a medium tree found in rain forests and savanna woodland, from sea-level up to the altitude of 2000 m [1, 2] . In Cameroon, the leaves, stems and roots of these plants are used in the treatment of gonococci, urinary infections and dysentery [3] . In addition, the fruit infusion of Z. leprieurii is shown to relegate the symptoms of sickle cell anemia [2] . The aqueous ethanolic extracts of the leaves, roots and stem bark of Z. leprieurii have demonstrated moderate antifungal activity while the chloroform extract of the fruits showed moderate cytotoxicity with the brine-shrimp assay [4, 5] . Recent reports on the dried fruits of Z. leprieurii from Cameroon described the isolation of acridone alkaloids that exhibited antiplasmodial activity and in vitro cytotoxicity [5, 6] . Its roots and stem bark have yielded alkaloids (benzophenanthridines, acridone, aporphine), aliphatic amides and lignans [5, 7, 8] . Several studies on Z. zanthoxyloides have established its broad spectrum of biological activities, including sickle cell anemia [9] [10] [11] . The antisickling divanylloylquinic acids as well as the antifungal and antioxidant isobutylamide and benzophenanthridine alkaloids have been reported from the roots [12] [13] [14] . From its fruits, the components of essential oils were also characterized [15, 16] . Besides the studies on its essential oil, no work has been carried out on the constituents of its non volatile extract. A recent study has revealed that the alcoholic extract of the fruits of this plant possessed in vitro cytotoxic activity against MCF-7, without identifying any bioactive constituents [17] . This prompted us to undertake a comparative study on the chemical constituents of the fruits of Z. zanthoxyloides and Z. leprieurii to identify their bioactive compounds.
In continuation of our work on the chemistry of medicinal and aromatic plants [18] [19] [20] [21] [22] , we have investigated the fruits of two Zanthoxylum species collected from Cameroon, Africa and recently reported their bioactive non-alkaloidal phytoconstituents [23, 24] . In the present paper, we describe the isolation and structure elucidation of several new acridone alkaloids, some of them with novel structures, from Z. zanthoxyloides and Z. leprieurii exhibiting antibacterial and cytotoxic activities. In order to explore the possible mechanism of these activities, we have also performed quantitative SAR of these acridones along with their molecular docking experiments to identify their putative biological targets.
Results and discussion

Isolation and identification of acridones
From the MeOH extract of the fruits of Z. zanthoxyloides, 6 new acridone alkaloids viz., 3-hydroxy-1,5,6-trimethoxy-9-acridone (1), 1,6-dihydroxy-3-methoxy-9-acridone (2), 3,4,5,7-tetrahydroxy-1-methoxy-10-methyl-9-acridone (3), 4-methoxyzanthacridone (8), 4-hydroxyzanthacridone (9), 4-hydroxyzanthacridone oxide (2,4') (10) along with two known acridones, viz., helebelicine A (4) and 1-hydroxy-3-methoxy-10-methyl-9-acridone (5), have been isolated and identified (Figure 1 ). Compounds 8-10 have a tetracyclic acridone carbon skeleton reported for the first time from Zanthoxylum spp. This novel acridone skeleton has, tentatively, been named as zanthacridone. From Z. leprieuri also, the new compound, 3-hydroxy-1,5,6-trimethoxy-9-acridone (1), was isolated along with three known acridones, namely, helebelicine A (4), 1,3-dihydroxy-4-methoxy-10-methyl-9-acridone (6) and tegerrardin A (7). All the compounds were Dragendorff positive and yellowish orange in color. The structures of the new compounds were elucidated mainly by UV, IR, NMR and MS spectroscopy (Additional file 1) and by comparison with the data already reported in the literature for acridone alkaloids [5, [25] [26] [27] [28] [29] [30] [31] [32] .
Compound 1 in its UV spectrum showed bands at 220, 233, 252 and 320 nm while in IR the bands appeared at 3448, 2929, 1620 cm -1 which suggested the presence of an acridone skeleton. Its molecular formula was determined by HRMS as C 16 H 15 O 5 N with [M] + at m/z 301.0944. On the basis of the molecular formula and the assumption of an acridone skeleton through comparison with the literature data for similar compounds [5] , compound 1 must be a trimethoxy-hydroxy-acridone. In the unsubstituted acridone, the signals of the peri-protons H-1 and H-8 are found at δ 8.25, while the neighbors of N-10 are found at approximately δ 7.5. It follows that the doublet at δ 7.99 ppm belongs to H-8; the coupling constant indicated a proton (H-7) in ortho-position. As the signal of H-7 did not show further couplings, the positions C-5 and C-6 must be oxygenated. It was further substantiated as in the 1 H 1 H COSY spectrum H-7 showed correlation only with H-8 and in HMBC it showed correlation with C-7-OMe at δ 61.9. Its 1 H NMR spectrum (Table 1 ) showed a downfield singlet at δ 9.02 for C-3-OH along with two meta coupled doublets (J = 3.0 Hz) at δ 7.01 and 7.55 indicating that C-1 and C-3 were substituted. The presence of three singlets at δ 4.40, 4.10 and 4.01 each of 3H in 1 H NMR spectrum and δ 61.9, 59.3 and 57.5 in its 13 C NMR spectrum indicated that it contained 3 OMe groups. The HMBC spectrum showed correlations as reported earlier [5] H NMR spectrum and at δ 158.0 and 61.9 for C-1-OMe in its 13 C NMR spectrum. The meta coupled doublets at δ 7.01 and 7.55 (J = 3.0 Hz) for H-2 and H-4 indicated that C-3 is also oxidized which was supported by the typical signal for C-3 in acridones at δ 152.6 in its 13 C NMR spectrum. The C-3-OH signal at δ 9.02 correlated with C-3 at δ 152.6 in its HMBC spectrum, clearly indicating the placement of phenol in A ring. The downfield signal at δ 7.99 in 1 H NMR spectrum which is typical for H-8 showed ortho coupling (J = 8.0 Hz) with H-7, correlation in 1 H 1 H COSY and no meta coupling, suggesting that two other methoxy groups are present at C-5 and C-6. The relatively strong upfield shifted C-4 signal at δ 104.8 in 13 C NMR spectrum for aromatic carbon fitted well with the earlier report [5] . The rest of the signals of 13 C NMR spectrum, when compared with the literature data, [5, 30, 33, 34] (Table 1) spectrum showed singlets at δ 12.12 and δ 8.90 for C-1-OH and C-6-OH, respectively, along with a relatively strong upfield singlet at δ 3.93 suggesting the presence of a methoxy group at C-3 in the acridone skeleton which was supported by the typical quartet at δ 56.4 in its 13 C NMR spectrum. The H COSY. These data suggested that the second hydroxyl group is attached at C-6. The relatively upfield shift of C-4 at δ 90.7 in 13 C NMR spectrum for aromatic carbon has been observed in earlier study [5] . The rest of 13 C NMR values (Experimental) accorded well with the structure for 2 as 1,6-dihydroxy-3-methoxy-9-acridone.
Compound 3 had the UV and IR bands for acridone alkaloids as described in the case of 1. Its HRMS showed [M] + at m/z 303.0734 corresponding to C 15 H 13 O 6 N. Its 1 H NMR spectrum showed four downfield singlets at δ 9.05, 9.32, 9.00 and 8.92 for phenolic protons. The downfield meta coupled doublet (J = 3.0 Hz) at δ 7.82 typical for H-8 in its 1 H NMR spectrum, clearly suggested that the doublet (J = 3.0 Hz) at δ 7.20 corresponds to H-6. Its 1 H NMR spectrum showed a typical downfield singlet at δ 4.44 for OMe at C-1 and δ 3.90 for N-Me which was supported by the quartets in 13 C NMR spectrum at δ 60.9 and 34.3, respectively. A singlet at δ 6.12 in the 1 H NMR spectrum further suggested that rest of the 3 carbons in A ring along with 2 in C ring are oxygenated which was strengthened by the presence of a total of five C-O-R signals in its 13 C NMR spectrum at δ 160.0, 161.3, 130.2, 146.2 and 143.1 for C-1, C-3, C-4, C-5 and C-7, respectively. The relatively strong upfield shift of C-4 at δ 130.2 for oxygenated carbon with N-10 methylated acridones fits well with the published data [5] . These data (Tables 1 and 2) established that 3 is 3,4,5, 7-tetrahydroxy-1-methoxy-10-methyl-9-acridone.
Compound 8 showed UV and IR spectral values for acridone skeleton as described in the case of 1. Its HRMS showed [M] + at m/z 355.1416 for C 20 H 21 O 5 N. An OH (H-bonded) singlet appeared at δ 15.05 in its 1 H NMR spectrum (Table 1) indicating the presence of a phenol at C-1. In its 1 H NMR spectrum, two sets of 13 C NMR spectrum (Table 2) . Since no signals, other than these four for C ring, were seen in the typically unsubstituted aromatic region in 1 H NMR spectrum of 8, it was concluded that all the four free carbons in A ring were substituted. The downfield signals at δ 162.1, 166.5 and 123.0 in its 13 C NMR spectrum implied that 3 carbons in A ring are oxygenated while 4th carbon is C-substituted. The relatively strong upfield shift of C-4 at δ 123.0 for oxygenated carbon with N-10 methylated acridones concurred well with previous report [5] . A set of additional signals in its 1 H NMR spectrum at δ 3.50 (dd, J = 10, 3.5 Hz), δ 2.72 and 3.07 (dd each, J = 13.0, 10.0 Hz) and two methyl singlets (6H) at δ 1.30 designated the presence of a three carbon chain attached with A ring. H COSY experiment showed a cyclic ring of -CH (OH)CH 2 C(O)(CH 3 ) 2 -attached at C-2 and C-3. Although the oxidation at C-3 is biogenetically preferred in this class of compounds, the HMBC experiment established that C-2 is C-substituted while C-3 is O-substituted. In HMBC spectrum, the signal for 4'-H at δ 3.50 showed strong correlation with C-2 at δ 118.2. This type of cyclization is justified by the 13 C NMR values at δ 79.6 (d), 28.1 (t), 73.4 (s) as well as 24.4 and 26.1 (q) along with C-2 and C-3 singlets at δ 118.2 and 166.5, respectively. In the NOESY spectrum of 8, the C-4'-H at δ 3.50 showed a weak correlation with phenolic proton at C-1 at δ 15.05 and no correlation with C-2'-Me, suggesting that OH at C-4' is β-oriented. The molecular model of 8 further reinforced this statement. Its HMQC and HMBC spectra also supported these observations (Experimental). The 3, 4-cyclization is normally preferred for a more stable linear structure of acridones. Recently, the linear tetracyclic acridones were reported from Glycosmis parva by Chansriniyom, et al. [25] having a double bond in pyran ring. Moreover, similar cyclization product was earlier reported from the synthesis of 1-hydroxy-1,2-dihydroisoacronycine by Magiatis et al. [35] but without oxidation at C-4. Acetylation of 8 yielded 8a showing the downfield shifting of CH(OH) from δ 3.50 to δ 4.34 along with an additional signal at δ 2.10 for OAc in its 1 H NMR spectrum. This observation clearly supported the presence of a CHOH group in this ring. Since the OMe appeared slightly upfield at δ 3.98 in 1 H NMR, it was placed at C-4 and not at C-1, obviously indicating that C-1 is substituted by a hydroxy group. The typical signals at δ 3.77 (s) in 1 H NMR and δ 30.5 (quartet) in 13 C NMR spectra justified the presence of N-Me. The present tetracyclic skeleton was, tentatively, named as zanthacridone and the data described as above supported the structure of 8 as 4-methoxyzanthacridone. Compound 9 had almost similar spectral data except the methoxy signal in 1 H NMR and 13 C NMR spectra (Tables 1 and 2 ) which clearly suggested that C-4 is now substituted with a hydroxy group rather than a methoxy, as was in case of compound 8. In its HRMS, [M] + appeared at m/z 341.1257 for C 19 H 19 O 5 N. Therefore, the structure of 9 was assigned as 4-hydroxyzanthacridone.
Compound 10 showed almost similar spectral data as 9 with the following exceptions: In its 1 H NMR spectrum, the CHOH appeared downfield at δ 4.85, as compared to 9 at δ 3.63; the -CH(OH)-also appeared more downfield at δ 92.3 in 10 than at δ 78.6 in compound 9 in its 13 C NMR spectrum. Moreover, a downfield shift was observed for C-2 from 117.5 in 9 to 160.2 in 10 in the 13 C NMR spectrum. The relatively strong upfield shift of C-4 at δ 131.2 for oxygenated carbon with N-10 methylated acridones, was also in accordance with earlier studies [5] . Acetylation of 10 gave a downfield shift of CHOH from δ 4.85 to δ 5.35 with an additional singlet for OAc at δ 2.11 in 1 H NMR spectrum. In the NOESY spectrum, one of the C-2'-Me at δ 1.32 correlated with C-4OH at δ 9.10 evidencing that there is no change in the position of the additional ring and happens to be quite similar as in case of 8 and 9. Since H-4' did not correlate with C-1 in its HMBC spectrum (as was in cases of 8 and 9), it was evident that there is an extra bond formation by an oxide between C-2 and C-4'. This observation fits well with the value of C-2 at δ 160.2 in its 13 C NMR spectrum. The C-4'-OH had a β-orientation as in its NOESY spectrum H-4' showed correlation with C-1-OH (Experimental) N. These data clearly supported the structure of 10 as 4-hydroxyzanthacridone oxide (2,4').
Biological evaluation
In vitro antibacterial evaluation
The results of the antibacterial activity of the isolated major acridones (1, 3, 4, 7, 8 and 10 ) against three Grampositive and one Gram-negative bacteria are given in Table 3 . Compound 3 exhibited moderate activity (MIC 125 μg/mL) when tested against Gram-positive Micrococcus luteus and Gram-negative Pseudomonas aeruginosa whereas 1, 8 and 10 showed activity against P. aeruginosa with MIC values of 500, 250 and 250 μg/mL, respectively. Compound 7 had MIC values of 500 and 250 μg/mL against Staphylococcus aureus and Bacillus subtilis, respectively (Table 3 ) while 4 displayed a MIC of 250 μg/mL against both bacteria. Against M. luteus, compounds 4 and 7 demonstrated a moderate activity with MIC 125 and 500 μg/mL, respectively but failed to show appreciable activity against P. aeruginosa. The present study related the antimicrobial activity with acridone alkaloids from the genus Zanthoxylum, although the acridones from the genus Boronea have exhibited this activity, earlier [36] .
Pharmacophore modeling and molecular docking studies against Glycosyltransferase (WAAG)
Since compounds 3 and 4 showed a MIC of 125 μg/mL against M. luteus, we carried out a quantitative SAR and molecular docking to explore the possible mechanism of action for the observed biological activities targeting glycosyltransferase. Results of pharmacophore modeling showed that compounds 1, 2, 3, 4, 9 and 10 have significant activity against M. luteus. Molecular docking study of these compounds against WAAG protein, a glycosyltransferase involved in lipopolysaccharide biosynthesis (PDB ID: 2IW1) [37] , revealed active conformation and interacting binding site amino acid residues (Figure 2 ). For validation of molecular docking co-crystallised uridine derivative was re-docked on bacterial protein WAAG (PDB: 2IW1) ( Table 4) . Compounds 3 and 4 were experimentally validated to be significantly active against M. luteus. Quantitative SAR studies showed that compounds 2 and 9 seem to be significantly active against M. luteus. However, experimentally non-active compounds 7 and 8 also predicted inactive against M. luteus. Moreover, compounds 1 and 10 were also predicted to be inactive against M. luteus (Table 5 ).
In vitro cytotoxicity evaluation
We screened compounds 1, 4, 7 and 8 for their in vitro cytotoxicity (Table 6 ) against liver (WRL-68), colon (CaCO2), breast (MCF-7) and prostate (PC-3) cancer cell lines using the MTT assay. We found that compounds 4 and 7 failed to produce a significant activity against the tested human cancer cell lines. However, a previous study [5] has reported 7 having a moderate antiproliferative activity against lung carcinoma and colorectal adenocarcinoma cell lines indicating that 7 possesses a selective cytotoxic activity. Compound 1 showed a moderate activity (IC 50 of 86 μM) against WRL-68; both 1 and 8 exhibited a poor activity against MCF-7 with IC 50 229 and 205 μM, respectively. Pharmacophore modeling and molecular docking studies against aromatase and quinone Reductase
Results of pharmacophore modeling showed that compounds 1, 8, 9 and 10 have significant activity against human anticancer target aromatase [38] . Molecular docking on human aromatase, quinone reductase, not on helicase [39] , was preferred because it is the popular enzyme in vertebrates known to catalyse the biosynthesis of all oestrogens from androgens and is therefore considered as a frontline therapy for oestrogen-dependent breast cancer [38] . Molecular docking study of studied compounds (1, 8, 9, 10) Figure 2 ). All compounds (1, 8, 9, 10) showed strong binding affinity with aromatase when compared with control molecule. Control experiment showed binding site residues namely, PHE-17, THR-147 with docking energy -5 .8 kcal/mol and two H-bonds. For validation of docking experiment, co-crystallised inhibitor 6-methoxy-9-methyl [1, 3] dioxolo [4,5-h] quinolin-8(9 h)-one was used as control molecule targeting anticancer protein aromatase (PDB: 3EQM), quinone reductase (PDB: 3G5M) ( Table 7) . Compounds 1 and 8 were experimentally validated to be significantly active against MCF-7 human breast cancer cell line. Results showed that out of ten compounds four showed significant anticancer activity against MCF-7 (Table 8) . Besides, all studied compounds showed compliance with Lipinski's rule of five parameters for drug likeness and oral bioavailability ( Table 9) .
Experimental
General experimental procedures 1 H and 13 C NMR spectra were obtained with a FT-NMR 300 MHz equipped with a 5 mm 1 H and 13 C (ATP) probe operating at 300 and 75 MHz, respectively, with TMS as internal standard. Chemical shifts were reported in δ (ppm) and coupling constants (J) were measured in Hz. QTOF-HRMS spectra were recorded on Agilent 6520-QTOF LC/MS having an ESI source in positive mode. Dry Nitrogen was used with 11 LPM flow rate for ionization at 350 Dc. The ESIMS was recorded on API-3000 LC-MS/MS ABSCIEX in 1.0 ppm solution through MS grade acetonitrile-water with injection mode: infusion through motor driven hardware syringe. UV analysis was carried out on a Spectronic Genesys 2 spectrophotometer and IR was recorded with FT-IR Perkin Elmer instrument. Optical rotations were taken with a Horiba SEPA-300 polarimeter. Melting points were determined on a Fisher-Johns melting point apparatus and were uncorrected. Precoated aluminium sheets silica gel 60 F254 TLC plates were used to check the purity of compounds and preparative TLC was performed on glass plates of silica gel 60 (20×20 cm, Merck). Flash chromatography was performed with a Buchi Pump manager C-615 flash model operating with two pump modules C-605. Spots were viewed under UV lamp (254 nm and 365 nm) or sprayed with Anisaldehyde-sulfuric acid and Draggendorff reagents. All reagents used, were of analytical grades.
Plant material
The dried fruits of Z. leprieurii and Z. zanthoxyloides were collected at Douala, Littoral Province of Cameroon in December 2009. The plants were identified at the University of Douala (TF) and the samples were compared with the voucher specimen number 2713/SRFK/ CAM and 21793/SFR/CAM for Z. leprieurii and Z. zanthoxyloides, respectively at the National Herbarium of Cameroon, Yaounde.
Extraction and isolation Extraction and isolation from Z. zanthoxyloides
The dried and ground fruits (400 g) were successively extracted under percolation at room temperature overnight with n-hexane three times. Thereafter, they were extracted by methanol at room temperature overnight which gave 16 g of crude extracts. A portion of this extract (10 g) was dissolved in CHCl 3 (30 mL) and extracted three times with 5 N HCL. The aqueous layer was basified with 25% ammonium hydroxide and the basic alkaloidal part was extracted with CHCl 3 (3×100 mL). The extract was dried over anhydrous sodium sulfate and solvent was evaporated. The extract (240 mg) obtained as above, after silica gel column chromatography (58 g, 
Extraction and isolation from Z. leprieurii
The dried fruits (380 g) after extraction as described above, yielded 48 g of methanol extract from which 40 g was dissolved in CHCl 3 (110 mL) and the alkaloids extracted as detailed above. The silica gel cc (120 g, 60-120 mesh, 2.5 × 100 cm) yielded complex mixtures (340 mg) which after flash chromatography (116 g, 230-400 mesh, 36 × 230 mm glass column C-690 Sepacore Buchi) using n-Hexane as solvent A and EtOAc plus 2 drops ammonium hydroxide/ 100 mL as solvent B with the flow rate stated as above, afforded eight fractions. Recrystallisation of fractions 3, 5 and 6 in MeOH-CHCl 3 afforded 7 (10 mg), 1 (3 mg) and 4 (40 mg), respectively. Compound 6 (5 mg) was obtained from fraction 7, after recrystallization in MeOH-CHCl 3 .
Spectroscopic data of new compounds Tables 1 and 2 Tables 1 and 2 
Acetylation of 4-hydroxyzanthacridone (9)
Using 1 mL of acetic anhydride and one drop of pyridine, 9 (2 mg) was acetylated and left for reflux at ambient temperature for 6 hrs. The reaction mixture after solvent evaporation under rotavapor yielded compound 9a. The threshold score (S) of 4.1274 has been selected for the screening of lead compounds. 
